Neuland Laboratories Limited (BOM:524558)
23,295
-267 (-1.14%)
At close: Aug 21, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 298.87 billion as of August 21, 2026. Its market cap has increased by 69.82% in one year.
Market Cap
298.87B
Enterprise Value
301.12B
Revenue
23.72B
Ranking
n/a
PE Ratio
60.04
Stock Price
23,294.80
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 298.87B, an increase of 89,077.69%. That is a compound annual growth rate of 30.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 298.87B | 53.35% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 159.30B |
| Suven Life Sciences | 98.21B |
| IOL Chemicals and Pharmaceuticals | 49.77B |
| Gujarat Themis Biosyn | 41.50B |
| Sai Parenteral's | 23.89B |
| NGL Fine-Chem | 18.28B |
| Bajaj HealthCare | 10.84B |
| Anlon Healthcare | 7.59B |